Objective: The aim of this study was to evaluate the survival benefit of sirolimus in patients
undergoing liver transplantation (LT) for hepatocellular carcinoma (HCC)(exploratory …

Simple Summary The ideal treatment for hepatocellular carcinoma (HCC) is liver
transplantation (LT), which both eliminates the HCC and cures the diseased liver. Once …

Immune checkpoint inhibitors (ICIs) have demonstrated remarkable efficacy in a variety of
solid tumors; nonetheless, they have not been well investigated and are still recognized as a …

OBJECTIVE. The purpose of this study is to compare imaging-based surveillance and
diagnostic strategies in patients at risk for hepatocellular carcinoma (HCC) while taking into …

Background Surgery is considered the only potentially curative treatment option for patients
with hepatocellular carcinoma. However, the chance that patients will eventually be “cured” …

Liver transplantation (LT) is the only potentially curative treatment for selected patients with
cirrhosis and hepatocellular carcinoma (HCC) who are not candidates for resection. When …

Hepatocellular carcinoma is one of the most lethal cancers in the United States. Early
detection of the disease is crucial for reducing the mortality of this malignancy. Recently, we …

Background and Aim A potential solution to the deceased organ shortage is to include live
organ donations and to identify patients with lower rates of HCC recurrence to fairly allocate …

Background Treatment of hepatocellular carcinoma (HCC) recurrences following liver
transplant (LT) is challenging. Most clinical trials of systemic therapies for advanced HCC …

Background: The presence of lymph node metastases is related to poor survival outcomes in
hepatocellular carcinoma patients and because of the reported low probability of lymph …